000 01956nam  2200337zi 4500
0019.933586
003CaOODSP
00520240221072804
006m     o  d f      
007cr mn|||||||||
008240207e202303  onca    ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay1y2
0861 |aHP5-216/2023E-PDF
24500|aEvaluation of the Public Health Agency of Canada's Autism Spectrum Disorder Program 2018-19 to 2021-22 / |cprepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.
264 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMarch 2023.
300 |a1 online resource (40 pages) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Évaluation du Programme sur le trouble du spectre de l'autisme de l'Agence de la santé publique du Canada de 2018-2019 à 2021-2022.
504 |aIncludes bibliographical references (pages 38-40).
61020|aPublic Health Agency of Canada|xEvaluation.
650 0|aAutism spectrum disorders|xGovernment policy|zCanada|xEvaluation.
650 0|aAutistic people|xServices for|zCanada|xEvaluation.
7102 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body.
77508|tÉvaluation du Programme sur le trouble du spectre de l'autisme de l'Agence de la santé publique du Canada de 2018-2019 à 2021-2022 / |w(CaOODSP)9.933851
85640|qPDF|s796 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-216-2023-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/autism-spectrum-disorder-program-2018-19-2021-22.html